Mesenchymal Stem Cells Alleviate Mouse Liver Fibrosis by Inhibiting Pathogenic Function of Intrahepatic B Cells

Researchers postulated that MSCs could potentially suppress the pro-fibrotic activity of intrahepatic B cells, thereby inhibiting liver fibrosis progression.